Skip to content
Medical Health Aged Care

DNP to Take Controlling-Stake in Laxton

Dai Nippon Printing Co., Ltd. 2 mins read

Maximizing synergies to accelerate the global expansion of biometric info-driven government authentication and security business


TOKYO--BUSINESS WIRE--

Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) entered into a share transfer agreement on June 17, 2025 to acquire Cayman Islands-headquartered Rubicon SEZC. Rubicon (a holding company of “Laxton” group) is a global Identity Systems Integrator that provides ID solutions for governments, primarily in developing nations, to register and authenticate personal information. DNP plans to acquire 75% of Rubicon's shares in July and complete the procedures to make the company a Group company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250613922077/en/

Products of Laxton

Products of Laxton

DNP will maximize synergies with Laxton in ID cards and card printers. By expanding to government-related business in Africa, Asia, South America, and other regions, we will further grow our authentication and security business, contributing to a safe and secure Smart Society.

[About Laxton]

Laxton develops ID authentication services using biometric information, primarily for governments in emerging countries and regions, such as Africa, and has a track record of implementation in over 50 countries and regions around the world. The company provides services that combine mobility, robustness, and security by housing ID registration and authentication devices and card printers in a portable case. Laxton provides one-stop services ranging from consulting to development, implementation, training, and maintenance to meet the needs of governments and other organizations, and has earned a high reputation in countries and regions around the world.

[Major Synergies from Laxton Acquisition]

  • Service improvement-driven business expansion
  • Expanding to emerging countries and regions where market growth is expected

[Going Forward]

DNP will seek to maximize synergies between our two companies through this acquisition, and aims to achieve cumulative sales of 140 billion yen by FY 2030 via ID authentication services for overseas governments.

More Details

About DNP

DNP was established in 1876, and has become a leading global company that leverages print-based solutions to engineer fresh business opportunities while protecting the environment and creating a more vibrant world for all. We capitalize on core competencies in microfabrication and precision coating technology to provide products for the display, electronic device, and optical film markets.


Contact details:

Media contact
DNP: Yusuke Kitagawa, +81-3-6735-0101
[email protected]

Media

More from this category

  • Medical Health Aged Care
  • 15/08/2026
  • 07:02
Optimi Health Corp.

Optimi Health Establishes Discretionary Equity Facility

VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it has entered into a common shares purchase agreement (the “Purchase Agreement”) with Seven Knots, LLC (“Seven Knots”), establishing an equity line of credit (the “ELOC”) under which the Company has the right, but not the obligation, to sell to Seven Knots up to US$100 million of its common shares from time to time over the term of the facility.Sales under the ELOC are at the…

  • Medical Health Aged Care, Research Development
  • 14/08/2026
  • 08:00
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG opens 2026 Fund for New Research Grants to accelerate the next generation of gynaecological cancer research

MEDIA RELEASE Friday, 14 August 2026 ANZGOG opens 2026 Fund for New Research Grants to accelerate the next generation of gynaecological cancer research The Australia New Zealand Gynaecological Oncology Group (ANZGOG) has today opened applications for its 2026 Fund for New Research Grant Program, supporting researchers to investigate promising ideas and generate the evidence needed to progress larger studies and future clinical trials. Supported by significant contributions from ANZGOG donors, the 2026 program will fund four priority research areas, with grants ranging from $50,000 to $100,000: Endometrial cancer focused surgical study – one grant of up to $55,000 Leiomyosarcoma focused…

  • Animal Animal WelfareRights, Medical Health Aged Care
  • 13/08/2026
  • 10:30
Monash University

Monash experts: Avian Influenza

Monash University experts are available to discuss the spread of H5 bird flu and its implications across native bird populations, agriculture, farming and general preparedness. Professor Anne Peters, specialist in the behaviour ecology and conservation of birds, Deputy Head of School of Biological Sciences,Monash University Contact details: +61 3 9903 4840 or [email protected] Read more Analysis and Opinion from Professor Peters The following can be attributed to Professor Peters: “Regarding theflu being detected in silver gulls, this is obviously very concerning. These seagulls are what many people know as the 'fish & chip' gull, i.e. they are common, range widely,…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.